Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.

Vannice, KS; Wilder-Smith, A; Barrett, ADT; Carrijo, K; Cavaleri, M; de Silva, A; Durbin, AP; Endy, T; Harris, E; Innis, BL; +5 more... Katzelnick, LC; Smith, PG; Sun, W; Thomas, SJ; Hombach, J; (2018) Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. Technical Report. Elsevier. DOI: https://doi.org/10.1016/j.vaccine.2018.02.062

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2018.02.062

Abstract

Share

Download

Filename: Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar